Coronary Artery Ectasia in Acute Coronary Syndrome: The Role of Non-vitamin K Antagonist Oral Anticoagulants in Management.

IF 0.2 0 PHILOSOPHY
Interventional Cardiology Review Pub Date : 2024-11-27 eCollection Date: 2024-01-01 DOI:10.15420/icr.2024.25
Mahmoud Izraiq, Nail Alshoubaki, Omran A Abu-Dhaim, Raed Aqel
{"title":"Coronary Artery Ectasia in Acute Coronary Syndrome: The Role of Non-vitamin K Antagonist Oral Anticoagulants in Management.","authors":"Mahmoud Izraiq, Nail Alshoubaki, Omran A Abu-Dhaim, Raed Aqel","doi":"10.15420/icr.2024.25","DOIUrl":null,"url":null,"abstract":"<p><p>Coronary artery ectasia (CAE) is an abnormal dilatation of coronary artery segments, often linked with atherosclerosis. This report discusses two cases of CAE presenting as acute coronary syndrome. A 36-year-old man had proximal blockage in the left circumflex artery (LCx) and ectasia in the obtuse marginal artery and left anterior descending artery (LAD), while a 53-year-old male smoker had an ectatic LAD with a substantial thrombus. Both were treated with dual antiplatelet therapy (aspirin and clopidogrel) and non-vitamin K antagonist oral anticoagulants (NOACs), specifically apixaban, along with atorvastatin. The first patient had complete resolution of LCx occlusion after 1 year, and the second patient had complete thrombus dissolution in the LAD in 2 months. These cases highlight the potential benefits of NOACs in managing CAE in acute coronary syndrome, suggesting that triple therapy can significantly improve clinical outcomes.</p>","PeriodicalId":38586,"journal":{"name":"Interventional Cardiology Review","volume":"19 ","pages":"e25"},"PeriodicalIF":0.2000,"publicationDate":"2024-11-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11702008/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Interventional Cardiology Review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15420/icr.2024.25","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"0","JCRName":"PHILOSOPHY","Score":null,"Total":0}
引用次数: 0

Abstract

Coronary artery ectasia (CAE) is an abnormal dilatation of coronary artery segments, often linked with atherosclerosis. This report discusses two cases of CAE presenting as acute coronary syndrome. A 36-year-old man had proximal blockage in the left circumflex artery (LCx) and ectasia in the obtuse marginal artery and left anterior descending artery (LAD), while a 53-year-old male smoker had an ectatic LAD with a substantial thrombus. Both were treated with dual antiplatelet therapy (aspirin and clopidogrel) and non-vitamin K antagonist oral anticoagulants (NOACs), specifically apixaban, along with atorvastatin. The first patient had complete resolution of LCx occlusion after 1 year, and the second patient had complete thrombus dissolution in the LAD in 2 months. These cases highlight the potential benefits of NOACs in managing CAE in acute coronary syndrome, suggesting that triple therapy can significantly improve clinical outcomes.

急性冠脉综合征冠状动脉扩张:非维生素K拮抗剂口服抗凝剂在治疗中的作用。
冠状动脉扩张(CAE)是冠状动脉段的异常扩张,通常与动脉粥样硬化有关。本报告讨论两例CAE表现为急性冠脉综合征。一名36岁男性左旋动脉(LCx)近端阻塞,钝边缘动脉和左前降支(LAD)扩张,而一名53岁男性吸烟者则有扩张的LAD伴大量血栓。两人均接受双重抗血小板治疗(阿司匹林和氯吡格雷)和非维生素K拮抗剂口服抗凝剂(NOACs),特别是阿哌沙班和阿托伐他汀。第1例患者1年后LCx闭塞完全解除,第2例患者2个月LAD内血栓完全溶解。这些病例强调了NOACs治疗急性冠脉综合征CAE的潜在益处,表明三联疗法可以显著改善临床结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Interventional Cardiology Review
Interventional Cardiology Review Medicine-Cardiology and Cardiovascular Medicine
CiteScore
0.30
自引率
0.00%
发文量
18
审稿时长
12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信